Pages

Wednesday, August 21, 2024

Rahul Gandhi Visits Top Srinagar Eatery For Dinner

SRINAGAR: Leader of Opposition in the Lok Sabha Rahul Gandhi on Wednesday visited a famous eatery in the heart of the city here to have dinner, a security official said.

Gandhi, along with Congress president Mallikarjun Kharge, left Hotel Lalit in the Gupkar area of the city, where they are staying, to dine at Hotel Ahdoos, one of the finest eateries in the city, famous for Kashmiri ‘Wazwan’, the person said.

It was not known whether the Congress leaders were only having dinner or meeting someone there.

The high-profile visit to the busy Polo View Residency Road area — the commercial hub of J-K’s summer capital — came as a surprise for everyone there.

A huge security ring was thrown around the hotel, which overlooks the Jhelum River during the visit. (PTI)

 


Indian Scientists Isolate Potent Bioactive Compounds from Himalayan Medicinal Plants

India Boosts Traditional Medicine Research with New AYUSH Initiatives
India has a rich history and tradition in the use of medicinal plants, which are integral to its traditional systems of medicine like Ayurveda, Unani, Siddha, and homeopathy. Research and Development (R&D) in medicinal plants in India is a vibrant field that spans traditional knowledge, modern scientific research, and industrial development. The country’s biodiversity and ancient medical heritage make it a global leader in medicinal plant R&D.

Key Areas of R&D in Medicinal Plants in India

  1. Traditional Medicine Systems and Integration
    • Ayurveda, Siddha, and Unani: These systems rely heavily on medicinal plants. R&D efforts focus on standardizing formulations, validating traditional knowledge with modern scientific methods, and integrating these systems with allopathic medicine.
    • Ethnobotanical Studies: Research into indigenous and tribal knowledge of medicinal plants is critical for preserving and documenting traditional uses, which often serve as a basis for further scientific research.
  2. Phytochemistry and Drug Discovery
    • Bioactive Compound Isolation: Indian R&D focuses on isolating and characterizing bioactive compounds from medicinal plants for potential therapeutic use.
    • Phytopharmaceuticals: Companies and research institutions work on developing standardized plant extracts and formulations with defined therapeutic effects. Examples include research on plants like Ashwagandha (Withania somnifera), Neem (Azadirachta indica), and Turmeric (Curcuma longa).
    • New Drug Development: Collaborations between Indian pharmaceutical companies and research institutes often focus on the discovery of new drugs derived from plants, targeting diseases like cancer, diabetes, and infectious diseases.
  3. Clinical Research and Validation
    • Clinical Trials: Rigorous clinical research is conducted to validate the efficacy and safety of plant-based treatments. For example, many Ayurvedic formulations undergo clinical testing to be accepted in modern medical practice.
    • Safety and Toxicology Studies: Toxicological evaluations ensure the safety of traditional and new herbal medicines, which is essential for gaining regulatory approval.
  4. Conservation and Sustainable Utilization
    • Conservation of Medicinal Plants: India’s R&D in this area includes projects aimed at conserving endangered medicinal plant species, both in situ (within their natural habitats) and ex situ (in botanical gardens and seed banks).
    • Sustainable Harvesting Practices: Research focuses on sustainable practices for cultivating and harvesting medicinal plants, particularly those in high demand, to prevent overexploitation.
    • National Medicinal Plants Board (NMPB): The NMPB, under the Ministry of AYUSH, plays a pivotal role in promoting the conservation, cultivation, and sustainable use of medicinal plants in India.
  5. Standardization and Quality Control
    • Quality Standards: Developing standardized processes for cultivation, extraction, and formulation of medicinal plant products is a major focus area. This ensures consistent quality and efficacy of herbal medicines.
    • Good Agricultural Practices (GAP): The adoption of GAP for medicinal plants is crucial for ensuring the quality of raw materials used in herbal products.
    • Quality Control Laboratories: India has established laboratories for testing the quality of medicinal plants and their products. These labs ensure that products meet national and international standards.
  6. Biotechnology and Genomics
    • Plant Biotechnology: Advances in plant tissue culture, genetic engineering, and molecular biology are used to enhance the yield of medicinal plants and produce bioactive compounds more efficiently.
    • Genomic Studies: R&D efforts in genomics help in understanding the genetic makeup of medicinal plants, which can lead to improved cultivation techniques and the discovery of new medicinal properties.
  7. Regulatory and Policy Support
    • Regulatory Framework: The Ministry of AYUSH, the Indian Council of Medical Research (ICMR), and the Central Council for Research in Ayurvedic Sciences (CCRAS) provide regulatory and policy support for R&D in medicinal plants.
    • Patent Protection: India has developed a Traditional Knowledge Digital Library (TKDL) to prevent biopiracy and ensure that traditional knowledge is properly documented and protected under intellectual property rights (IPR).

Major Institutions Involved in Medicinal Plant R&D in India

  1. National Medicinal Plants Board (NMPB): Focuses on promoting the cultivation and conservation of medicinal plants and providing support for R&D in this area.
  2. Central Council for Research in Ayurvedic Sciences (CCRAS): Conducts and coordinates research on Ayurveda, including medicinal plant research.
  3. Indian Council of Medical Research (ICMR): Engages in biomedical research, including studies on medicinal plants and herbal drugs.
  4. Central Drug Research Institute (CDRI): A premier research institution focusing on drug discovery and development, including plant-based drugs.
  5. Jammu and Kashmir Medicinal Plants Introduction Centre (JKMPIC): Specializes in the study of medicinal plants found in the Himalayan region.
  6. Central Institute of Medicinal and Aromatic Plants (CIMAP): Engages in R&D on medicinal and aromatic plants, including phytochemistry, genetics, and biotechnology.
  7. National Botanical Research Institute (NBRI): Focuses on botanical research, including the identification and conservation of medicinal plants.

Commercialization and Market Potential

  • Phytopharmaceutical Industry: The Indian herbal medicine market is growing rapidly, driven by the increasing demand for natural products. Indian companies are developing standardized herbal medicines and nutraceuticals for both domestic and international markets.
  • Export of Medicinal Plants and Products: India is a major exporter of medicinal plants and herbal products, including essential oils, extracts, and finished products. The demand for Indian medicinal plants in global markets continues to rise, particularly in Europe and North America.

Challenges and Opportunities

  • Biodiversity Conservation: Balancing commercial exploitation with the need for conservation is a challenge. Overharvesting and habitat loss threaten the sustainability of some medicinal plants.
  • Quality Control: Ensuring consistent quality and standardization of herbal products remains a challenge, especially for exports.
  • Intellectual Property: Protecting traditional knowledge and ensuring equitable benefit-sharing with indigenous communities is crucial for ethical R&D practices.

India's vast biodiversity, coupled with its rich heritage of traditional medicine, provides immense opportunities for R&D in medicinal plants. With continued focus on conservation, sustainable utilization, and modern scientific validation, India is well-positioned to be a global leader in medicinal plant research and development.

  • Traditional Knowledge Digital Library, (TKDL)
  • Good Agricultural Practices, (GAP)
  • Conservation of Medicinal Plants,